Half-lifeUnknown in humans when injected; thought to be short
Vial sizes50 mg, 100 mg
The simple version
What it does
It helps skin make collagen and heal, shown mostly with creams and in lab studies.
How people take it
People who inject it typically use 1–2 mg once a day.
Know this
Creams have some small human studies, but injecting it has never been tested in a human trial.
What it is
GHK is a tiny peptide, just three amino acids, found in your blood, saliva and urine. It grabs copper tightly, the pair is called GHK-Cu, and blood levels drop as you age. It's been a common ingredient in anti-aging skin creams and hair serums for decades.
How it works
GHK-Cu delivers copper to cells that need it for repair. In lab studies it tells skin cells to make more collagen and elastin, the proteins that keep skin firm, and it calms inflammation and helps wounds close. Gene studies suggest it nudges many repair genes at once, but that's lab data, not proof it works in people.
What people use it for
Skin firmness, fine lines and texture
Hair thinning (serums you put on)
Wound and scar healing
General anti-aging
The evidence
Some human studies
On skin, small cosmetic studies, many run or paid for by the industry, show modest gains in firmness and fine lines, and lab and animal studies show wound healing and collagen effects. Injected GHK-Cu, which many people now use, has no published human trials, and FDA has noted there's little human data for injecting it. Treat any whole-body anti-aging claims as unproven.
We may earn a commission from these links. Counts include one syringe and two swabs per dose.
Stay safe
Side effects
Stinging or burning where you inject (common)
Redness, bumps or small lumps at the shot site
Skin irritation from creams in sensitive people
Unknown long-term effects of injecting it
Skip it if
Wilson's disease or any condition where your body can't process copper properly
Copper allergy
History of cancer or a current tumor (it helps grow new blood vessels)
Pregnant or breastfeeding
Under 18
Interactions
Copper supplements or multivitamins with copper add to your total copper intake
On skin: strong acids or vitamin C used in the same step can break down the peptide
Get help right away for swelling of the face or throat, trouble breathing, chest pain, or a spreading, hot, red injection site.
Storage & legal
Storage
Powder: fridge or freezer, out of light. Once mixed with bacteriostatic water: fridge, use within about 4 weeks. Creams: follow the label.
Legal status
FDA: Legal as a cosmetic ingredient in skin and hair products. Injectable GHK-Cu is not approved. FDA removed injectable GHK-Cu from its Category 2 compounding risk list in April 2026 after the nomination was withdrawn. It is not on the 503A bulks list.
Sport (WADA): Not named on the list. Skin products are not an issue, but injected use could fall under S0 (non-approved substances); athletes should check with their anti-doping agency.
The cream has the longer track record and some small human studies. The injection has no published human trials.
Why is the liquid blue?
The copper makes it blue. That's normal.
Why does the injection sting?
Copper irritates the tissue under the skin. Many people dilute it more or rotate injection spots to make it more comfortable.
How do people use the cream?
Once or twice a day on clean skin or scalp, then judge results after 8 to 12 weeks. Skip strong acids or vitamin C in the same step, since they can break the copper bond.
Sources
Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. PubMed 26236730
Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PubMed 29986520
Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88. PubMed 18644225
Dou Y, et al. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2(1):58-61. PubMed 35083444
FDA. Certain bulk drug substances for use in compounding that may present significant safety risks (updated April 22, 2026). Source